Cross-relationship between COVID-19 infection and anti-obesity products efficacy and incidence of side effects: A cross-sectional study
Concurrent AOPs intake with COVID-19 infection is a two-sided weapon; AOPs attenuate COVID-19 infection, while SARS-CoV-2 interferes with efficacy and side effects incidence of AOPs.
Authors
- Nilly A. Shams
- Mai Moaaz (ORCID: https://orcid.org/0000-0001-5854-7736)
- D. Khalifa
- Nesrine S. El-Mezayen (ORCID: https://orcid.org/0000-0003-2418-453X)
- Axam Abdelhadi
- Irinie Adly
- Yasser R. Abelrazik
- Nada M. Dorbouk
- Alaa G. Evy
- Merna M. Ali
- Elshaimaa G. Mohamed
Institutions
- Pharos University in Alexandria (EG)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-08-22
- DOI
- https://doi.org/10.1371/journal.pone.0309323
- Citations
- 1
- Primary Topic
- Pharmacology and Obesity Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.45